|
1
|
Lavanchy D: The global burden of hepatitis
C. Liver Int. 29(Suppl 1): 74–81. 2009. View Article : Google Scholar
|
|
2
|
Lauer GM and Walker BD: Hepatitis C virus
infection. N Engl J Med. 345:41–52. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyer N and Marcellin P: Pathogenesis,
diagnosis and management of hepatitis C. J Hepatol. 32(Suppl 1):
98–112. 2000. View Article : Google Scholar
|
|
4
|
Clarke DC and Liu X: Decoding the
quantitative nature of TGF-beta/Smad signaling. Trends Cell Biol.
18:430–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li MO, Sanjabi S and Flavell RA:
Transforming growth factor-beta controls development, homeostasis,
and tolerance of T cells by regulatory T cell-dependent and
-independent mechanisms. Immunity. 25:455–471. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nelson DR, Gonzalez-Peralta RP, Qian K, et
al: Transforming growth factor-beta 1 in chronic hepatitis C. J
Viral Hepat. 4:29–35. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Andrade DR Jr and de Andrade DR: The
influence of the human genome on chronic viral hepatitis outcome.
Rev Inst Med Trop Sao Paulo. 46:119–126. 2004.PubMed/NCBI
|
|
8
|
Tsushima H, Kawata S, Tamura S, et al:
Reduced plasma transforming growth factor-beta1 levels in patients
with chronic hepatitis C after interferon-alpha therapy:
association with regression of hepatic fibrosis. J Hepatol. 30:1–7.
1999. View Article : Google Scholar
|
|
9
|
Kondo Y, Ueno Y and Shimosegawa T:
Dysfunction of immune systems and host genetic factors in hepatitis
C virus infection with persistent normal ALT. Hepat Res Treat.
2011:7132162011.PubMed/NCBI
|
|
10
|
Fujii D, Brissenden JE, Derynck R and
Francke U: Transforming growth factor beta gene maps to human
chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol
Genet. 12:281–288. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grainger DJ, Heathcote K, Chiano M, et al:
Genetic control of the circulating concentration of transforming
growth factor type beta1. Hum Mol Genet. 8:93–97. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ben-Ari Z, Pappo O, Druzd T, et al: Role
of cytokine gene polymorphism and hepatic transforming growth
factor beta1 expression in recurrent hepatitis C after liver
transplantation. Cytokine. 27:7–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Falleti E, Fabris C, Toniutto P, et al:
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence
of liver cancer. Cytokine. 44:256–261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vidigal PG, Germer JJ and Zein NN:
Polymorphisms in the interleukin-10, tumor necrosis factor-alpha,
and transforming growth factor-beta1 genes in chronic hepatitis C
patients treated with interferon and ribavirin. J Hepatol.
36:271–277. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Romani S, Azimzadeh P, Mohebbi SR, et al:
Investigation of transforming growth factor-beta1 gene
polymorphisms among Iranian patients with chronic hepatitis C.
Hepat Mon. 11:901–906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pereira FA, Pinheiro da Silva NN, Rodart
IF, Carmo TM, Lemaire DC and Reis MG: Association of TGF-beta1
codon 25 (G915C) polymorphism with hepatitis C virus infection. J
Med Virol. 80:58–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang J, Liu ZW and Han QY: Polymorphism of
codon25 in signal peptide region of transforming growth factor beta
1 and its association with chronic hepatitis C virus infection.
Chin J Hepatol. 6:586–589. 2008.(In Chinese).
|
|
18
|
Armendariz-Borunda J, Rincon AR,
Munoz-Valle JF, et al: Fibrogenic polymorphisms (TGF-beta, PAI-1,
AT) in Mexican patients with established liver fibrosis. Potential
correlation with pirfenidone treatment. J Investig Med. 56:944–953.
2008.
|
|
19
|
Wang H, Mengsteab S, Tag CG, et al:
Transforming growth factor-beta1 gene polymorphisms are associated
with progression of liver fibrosis in Caucasians with chronic
hepatitis C infection. World J Gastroenterol. 11:1929–1936. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zein NN, Germer JJ, El-Zayadi AR and
Vidigal PG: Ethnic differences in polymorphisms of tumor necrosis
factor-alpha, interleukin-10, and transforming growth factor-beta1
genes in patients with chronic hepatitis C virus infection. Am J
Trop Med Hyg. 70:434–437. 2004.PubMed/NCBI
|
|
21
|
Suzuki S, Tanaka Y, Orito E, et al:
Transforming growth factor-beta-1 genetic polymorphism in Japanese
patients with chronic hepatitis C virus infection. J Gastroenterol
Hepatol. 18:1139–1143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thakkinstian A, McElduff P, D’Este C,
Duffy D and Attia J: A method for meta-analysis of molecular
association studies. Stat Med. 24:1291–1306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Attia J, Thakkinstian A and D’Este C:
Meta-analyses of molecular association studies: methodologic
lessons for genetic epidemiology. J Clin Epidemiol. 56:297–303.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
25
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paul SR and Donner A: Small sample
performance of tests of homogeneity of odds ratios in K 2×2 tables.
Stat Med. 11:159–165. 1992.PubMed/NCBI
|
|
27
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H
and Moons KG: More than numbers: the power of graphs in
meta-analysis. Am J Epidemiol. 169:249–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ascione A, Tartaglione T and Di Costanzo
GG: Natural history of chronic hepatitis C virus infection. Dig
Liver Dis. 39(Suppl 1): S4–S7. 2007. View Article : Google Scholar
|
|
30
|
Roffi L, Ricci A, Ogliari C, et al: HCV
genotypes in Northern Italy: a survey of 1368 histologically proven
chronic hepatitis C patients. J Hepatol. 29:701–706. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeuzem S, Franke A, Lee JH, Herrmann G,
Ruster B and Roth WK: Phylogenetic analysis of hepatitis C virus
isolates and their correlation to viremia, liver function tests,
and histology. Hepatology. 24:1003–1009. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bortolotti F, Resti M, Marcellini M, et
al: Hepatitis C virus (HCV) genotypes in 373 Italian children with
HCV infection: changing distribution and correlation with clinical
features and outcome. Gut. 54:852–857. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lehmann M, Meyer MF, Monazahian M,
Tillmann HL, Manns MP and Wedemeyer H: High rate of spontaneous
clearance of acute hepatitis C virus genotype 3 infection. J Med
Virol. 73:387–391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bellanti F, Vendemiale G, Altomare E and
Serviddio G: The impact of interferon lambda 3 gene polymorphism on
natural course and treatment of hepatitis C. Clin Dev Immunol.
2012:8493732012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Birerdinc A, Afendy A, Stepanova M,
Younossi I, Baranova A and Younossi ZM: Gene expression profiles
associated with depression in patients with chronic hepatitis C
(CH-C). Brain Behav. 2:525–531. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hall CH, Kassel R, Tacke RS and Hahn YS:
HCV+hepatocytes induce human regulatory CD4+T
cells through the production of TGF-beta. PloS One.
5:e121542010.PubMed/NCBI
|
|
37
|
Dooley S and ten Dijke P: TGF-beta in
progression of liver disease. Cell Tissue Res. 347:245–256. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Presser LD, Haskett A and Waris G:
Hepatitis C virus-induced furin and thrombospondin-1 activate
TGF-beta1: role of TGF-beta1 in HCV replication. Virology.
412:284–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Awad MR, El-Gamel A, Hasleton P, Turner
DM, Sinnott PJ and Hutchinson IV: Genotypic variation in the
transforming growth factor-beta1 gene: association with
transforming growth factor-beta1 production, fibrotic lung disease,
and graft fibrosis after lung transplantation. Transplantation.
66:1014–1020. 1998.PubMed/NCBI
|
|
40
|
Presser LD, McRae S and Waris G:
Activation of TGF-beta1 promoter by hepatitis C virus-induced AP-1
and Sp1: role of TGF-beta1 in hepatic stellate cell activation and
invasion. PloS One. 8:e563672013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mehmedovic A, Mesihovic R, Prnjavorac B,
et al: Non-invasive liver fibrosis markers: use of serum levels of
cytokines IL 1α and TGF β1 in management of chronic liver diseases.
Med Glas (Zenica). 10:20–27. 2013.PubMed/NCBI
|
|
42
|
Powell EE, Edwards-Smith CJ, Hay JL, et
al: Host genetic factors influence disease progression in chronic
hepatitis C. Hepatology. 31:828–833. 2000. View Article : Google Scholar : PubMed/NCBI
|
